Has Mark Thompson received payments from drug or device companies?

Yes. Drug and device makers reported $6,625 in general payments to Mark Thompson across 365 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Thompson did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Thompson come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Thompson

Medical · Detroit, MINPI 1265441729

Payments from drug & device makers

$6,625in general payments, 2019–2025

Across 365 payments — averaging $18.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Gilead$2K
Viiv Healthcare Company$2K
AbbVie$996
Ironwood Pharmaceuticals, Inc$354
GSK$256
Merck$230
plus $1K from 23 others

What the payments were for

Food & beverage$6,605100%
Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Gilead	75	$1,727
Viiv Healthcare Company	112	$1,624
AbbVie	60	$996
Ironwood Pharmaceuticals, Inc	20	$354
GSK	11	$256
Merck	10	$230
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	10	$215
Otsuka America Pharmaceutical, Inc.	9	$176
Boehringer Ingelheim	6	$134
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	8	$129
Takeda Pharmaceuticals U.S.A., Inc.	6	$103
Novo Nordisk	5	$82
Pfizer	3	$62
EMD Serono, Inc.	2	$60
Exact Sciences	3	$59
Antares Pharma, Inc.	3	$55
AstraZeneca	4	$51
Johnson & Johnson	2	$48
Hologic Sales And Service, LLC	2	$42
Biohaven Pharmaceutical Holding Company Ltd.	2	$33
Theratechnologies Inc.	2	$33
Amarin Pharma, Inc.	2	$33
Biohaven Pharmaceuticals, Inc.	2	$29
Boston Scientific	1	$21
Eisai Inc.	1	$21
Lilly USA, LLC	1	$14
Aimmune Therapeutics, Inc.	1	$14
Nestle Healthcare Nutrition Inc.	1	$12
Novartis	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TRELEGY ELLIPTA$125

How this compares

$6,625 in reported general payments places this provider in the 90th percentile of 755 medical providers in Michigan.

See all medical providers in Michigan →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala	44	$176,666
CabenuvaCabotegravir/Rilpivirine	11	$67,149
PrezcobixDarunavir/Cobicistat	14	$34,051
JardianceEmpagliflozin	14	$15,930
EliquisApixaban	11	$14,530
OzempicSemaglutide	14	$13,435
Albuterol Sulfate HfaAlbuterol Sulfate	60	$1,972
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	11	$1,068
Comfort Ez Pen NeedlePen Needle, Diabetic	13	$985
Testosterone Cypionate	47	$752
Ibuprofen	39	$513
Atorvastatin Calcium	43	$474
Rosuvastatin Calcium	18	$427
Metoprolol Succinate	23	$355
Losartan Potassium	47	$318

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
GileadBiktarvy	$1,727	$176,66644 claims
Viiv Healthcare CompanyCabenuva	$1,624	$67,14911 claims
Johnson & JohnsonPrezcobix	$48	$34,05114 claims
Boehringer IngelheimJardiance	$134	$15,93014 claims
PfizerEliquis	$62	$14,53011 claims
Novo NordiskOzempic	$82	$13,43514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 755 medical providers in Michigan.

Other medical in Detroit

John BrabantDetroit$26K
Kimberly BelzerDetroit$16K
Linda RyznarDetroit$16K
Caleb YoungbloodBerkley$215K
Steven StoneKalamazoo$200K
Meredith KentGrand Rapids$192K
Amber ShullNorton Shores$154K
Jason EvansWaterford$104K
James ToreySaint Clair Shores$66K
David WilkinsMuskegon$41K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →